Laursen T - Search Results

1

Different effects of continuous and intermittent patterns of growth hormone administration on lipoprotein levels in growth hormone-deficient patients.

Laursen T, Lemming L, Jørgensen JO, Klausen IC, Christiansen JS. Laursen T, et al. Horm Res. 1998;50(5):284-91. doi: 10.1159/000023292. Horm Res. 1998. PMID: 9873197 Clinical Trial.

2

Mortality and reduced growth hormone secretion.

Stochholm K, Christiansen J, Laursen T, Gravholt CH. Stochholm K, et al. Among authors: laursen t. Horm Res. 2007;68 Suppl 5:173-6. doi: 10.1159/000110618. Epub 2007 Dec 10. Horm Res. 2007. PMID: 18174740 Review.

3

The management of adult growth hormone deficiency syndrome.

Laursen T, Jørgensen JO, Christiansen JS. Laursen T, et al. Expert Opin Pharmacother. 2008 Oct;9(14):2435-50. doi: 10.1517/14656566.9.14.2435. Expert Opin Pharmacother. 2008. PMID: 18778182 Review.

4

Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients.

Laursen T, Jørgensen JO, Orskov H, Møller J, Harris AG, Christiansen JS. Laursen T, et al. Acta Endocrinol (Copenh). 1993 Nov;129(5):399-408. doi: 10.1530/acta.0.1290399. Acta Endocrinol (Copenh). 1993. PMID: 7506470 Clinical Trial.

5

Pharmacokinetics and metabolic effects of growth hormone injected subcutaneously in growth hormone deficient patients: thigh versus abdomen.

Laursen T, Jørgensen JO, Christiansen JS. Laursen T, et al. Clin Endocrinol (Oxf). 1994 Mar;40(3):373-8. doi: 10.1111/j.1365-2265.1994.tb03934.x. Clin Endocrinol (Oxf). 1994. PMID: 7514513 Clinical Trial.

6

Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.

Laursen T, Jørgensen JO, Christiansen JS. Laursen T, et al. Clin Endocrinol (Oxf). 1994 Sep;41(3):337-43. doi: 10.1111/j.1365-2265.1994.tb02554.x. Clin Endocrinol (Oxf). 1994. PMID: 7525120 Clinical Trial.

7

Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.

Laursen T, Jørgensen JO, Jakobsen G, Hansen BL, Christiansen JS. Laursen T, et al. J Clin Endocrinol Metab. 1995 Aug;80(8):2410-8. doi: 10.1210/jcem.80.8.7543114. J Clin Endocrinol Metab. 1995. PMID: 7543114 Clinical Trial.

8

Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults.

Jørgensen JO, Møller J, Laursen T, Orskov H, Christiansen JS, Weeke J. Jørgensen JO, et al. Among authors: laursen t. Clin Endocrinol (Oxf). 1994 Nov;41(5):609-14. doi: 10.1111/j.1365-2265.1994.tb01826.x. Clin Endocrinol (Oxf). 1994. PMID: 7828350

9

Nasal absorption of growth hormone in normal subjects: studies with four different formulations.

Laursen T, Ovesen P, Grandjean B, Jensen S, Jørgensen JO, Illum P, Christiansen JS. Laursen T, et al. Ann Pharmacother. 1994 Jul-Aug;28(7-8):845-8. doi: 10.1177/106002809402800703. Ann Pharmacother. 1994. PMID: 7949497 Clinical Trial.

10

Absorption kinetics of two highly concentrated preparations of growth hormone: 12 IU/ml compared to 56 IU/ml.

Laursen T, Susgaard S, Jensen FS, Jørgensen JO, Christiansen JS. Laursen T, et al. Pharmacol Toxicol. 1994 Jan;74(1):54-7. doi: 10.1111/j.1600-0773.1994.tb01074.x. Pharmacol Toxicol. 1994. PMID: 8159637 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters